Dr. Keri Lestage

Chief Revenue Officer
Voran Group

Dr. Lestage holds a B.S in Biochemical Engineering from the University of Western Ontario and earned her Ph.D. in Polymer Science and Engineering from the University of Southern Mississippi, specializing in functional coatings.

Her career journey began in the field of research and development at the Clorox Company, where she honed her expertise in disinfectant formulation, public health program implementation, and distribution strategy. Over the course of 12 years, Dr. Lestage assumed various leadership roles in R&D at Clorox, culminating in her role as the Associate Director of Strategic Partnerships for the Healthcare and Professional Products Division.

In 2017, Dr. Lestage took on a pivotal role at Byoplanet International, a leading manufacturer of state-of-the-art electrostatic spray technology. She served as the Chief Operations Officer until 2021 and later transitioned into the role of Chief Science Officer during the pandemic. Her contributions were instrumental in making her a recognized expert in infection control technologies within the cleaning industry.

Building upon her 20 years of experience, Dr. Lestage embarked on an entrepreneurial journey in 2023. She founded a business that offers fractional Chief Operations Officer (COO), Chief Revenue Officer (CRO), and Chief Science Officer (CSO) roles to start-up and mid-size organizations. Her focus encompasses strategic partnerships, product development, go-to-market strategies, distribution, and manufacturing operations. To date, she has successfully served several clients in Canada, the United States and Europe.

Additionally, Dr. Lestage plays an active role in the healthcare industry as a advisory council member of the Healthcare Surfaces Institute. In this capacity, she connects key stakeholders to address the critical issue of surfaces as a vector for Healthcare-Associated Infections (HAI’s).